G. Monterossi, L. Pedone Anchora, S. Gueli Alletti, A. Fagotti, F. Fanfani, G. Scambia
{"title":"欧洲首个使用新型手术机器人Hugo™RAS的妇科手术。1例BRCA-1突变患者行全子宫切除和输卵管卵巢切除术","authors":"G. Monterossi, L. Pedone Anchora, S. Gueli Alletti, A. Fagotti, F. Fanfani, G. Scambia","doi":"10.52054/FVVO.14.1.014","DOIUrl":null,"url":null,"abstract":"Background The benefits of minimally invasive surgery are well known in gynaecology. Robotic-assisted surgery has gained widespread acceptance within the surgical community and seems to be the most rapidly developing sector of minimally invasive surgery. Objectives This video shows the salient steps of total hysterectomy with new robotic technology, Hugo™ RAS. The objectives were to introduce and demonstrate the feasibility, efficacy, and safety of this new advanced device. Materials and Methods A sixty-two years-old woman affected by BRCA-1 mutation underwent the first European gynaecological surgical procedure using the new surgical robot Hugo™ RAS in the Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. Main outcome measures Docking and operative times. Results The docking time was 6 minutes and the total operative time was 58 minutes. There were no system errors and faults in the robotic arms. The surgeon found no friction or rasping in the arms. The estimated blood loss was 30 mL. No intraoperative complications were recorded. Conclusion Gynaecological surgery with Hugo™ RAS seems feasible, safe and effective as shown by initial experiences in urological surgery. A larger case series would confirm the current experience and determine whether this technology could offer any additional benefit.","PeriodicalId":46400,"journal":{"name":"Facts Views and Vision in ObGyn","volume":"14 1","pages":"91 - 94"},"PeriodicalIF":1.7000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"13","resultStr":"{\"title\":\"The first European gynaecological procedure with the new surgical robot Hugo™ RAS. A total hysterectomy and salpingo-oophorectomy in a woman affected by BRCA-1 mutation\",\"authors\":\"G. Monterossi, L. Pedone Anchora, S. Gueli Alletti, A. Fagotti, F. Fanfani, G. Scambia\",\"doi\":\"10.52054/FVVO.14.1.014\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background The benefits of minimally invasive surgery are well known in gynaecology. Robotic-assisted surgery has gained widespread acceptance within the surgical community and seems to be the most rapidly developing sector of minimally invasive surgery. Objectives This video shows the salient steps of total hysterectomy with new robotic technology, Hugo™ RAS. The objectives were to introduce and demonstrate the feasibility, efficacy, and safety of this new advanced device. Materials and Methods A sixty-two years-old woman affected by BRCA-1 mutation underwent the first European gynaecological surgical procedure using the new surgical robot Hugo™ RAS in the Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. Main outcome measures Docking and operative times. Results The docking time was 6 minutes and the total operative time was 58 minutes. There were no system errors and faults in the robotic arms. The surgeon found no friction or rasping in the arms. The estimated blood loss was 30 mL. No intraoperative complications were recorded. Conclusion Gynaecological surgery with Hugo™ RAS seems feasible, safe and effective as shown by initial experiences in urological surgery. A larger case series would confirm the current experience and determine whether this technology could offer any additional benefit.\",\"PeriodicalId\":46400,\"journal\":{\"name\":\"Facts Views and Vision in ObGyn\",\"volume\":\"14 1\",\"pages\":\"91 - 94\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2022-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"13\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Facts Views and Vision in ObGyn\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52054/FVVO.14.1.014\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Facts Views and Vision in ObGyn","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52054/FVVO.14.1.014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 13
摘要
背景微创手术在妇科的好处是众所周知的。机器人辅助手术在外科界得到了广泛的接受,似乎是微创手术中发展最快的领域。目的:本视频展示了采用新型机器人技术Hugo™RAS进行全子宫切除术的主要步骤。目的是介绍和证明这种新的先进设备的可行性、有效性和安全性。材料和方法一名患有BRCA-1突变的62岁女性在意大利罗马的Fondazione Policlinico Universitario A. Gemelli IRCCS妇科肿瘤科使用新型手术机器人Hugo™RAS接受了首次欧洲妇科手术。主要观察指标:对接和手术时间。结果对接时间6分钟,总手术时间58分钟。机械臂上没有系统错误和故障。外科医生没有发现手臂上的摩擦或摩擦。估计失血量为30ml,无术中并发症记录。结论从泌尿外科的初步经验来看,Hugo™RAS在妇科手术中是可行、安全、有效的。一个更大的案例系列将证实目前的经验,并确定这项技术是否可以提供任何额外的好处。
The first European gynaecological procedure with the new surgical robot Hugo™ RAS. A total hysterectomy and salpingo-oophorectomy in a woman affected by BRCA-1 mutation
Background The benefits of minimally invasive surgery are well known in gynaecology. Robotic-assisted surgery has gained widespread acceptance within the surgical community and seems to be the most rapidly developing sector of minimally invasive surgery. Objectives This video shows the salient steps of total hysterectomy with new robotic technology, Hugo™ RAS. The objectives were to introduce and demonstrate the feasibility, efficacy, and safety of this new advanced device. Materials and Methods A sixty-two years-old woman affected by BRCA-1 mutation underwent the first European gynaecological surgical procedure using the new surgical robot Hugo™ RAS in the Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. Main outcome measures Docking and operative times. Results The docking time was 6 minutes and the total operative time was 58 minutes. There were no system errors and faults in the robotic arms. The surgeon found no friction or rasping in the arms. The estimated blood loss was 30 mL. No intraoperative complications were recorded. Conclusion Gynaecological surgery with Hugo™ RAS seems feasible, safe and effective as shown by initial experiences in urological surgery. A larger case series would confirm the current experience and determine whether this technology could offer any additional benefit.